Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Men with untreated male pattern hair loss continue to lose hair over a 5-year period.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Zinc and iron levels drop after bariatric surgery, needing careful monitoring and supplements.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Bioprinting is advancing towards creating personalized tissues and organs, but challenges remain for clinical use.

Stress worsens hair loss in androgenetic alopecia.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Dermatologists are more comfortable and proactive in treating male pattern hair loss than primary care physicians.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Dupilumab may worsen hair loss in patients with alopecia areata.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

PRP therapy's success varies and depends on PRP quality and patient condition, with athletes benefiting more.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Transplantation is effective for stable leucoderma but not for progressive, widespread vitiligo vulgaris.